Thinking Allowed

Gene therapy staves off blindness from retinitis pigmentosa in canine model: Gene therapy preserved vision in a study involving

2015-10-18 00:57:33

Gene therapy staves off blindness from retinitis pigmentosa in canine model: Gene therapy preserved vision in a study involving dogs with naturally occurring, late-stage retinitis pigmentosa, according to research funded by the National Eye Institute, part of the National Institutes of Health. The findings contribute to the groundwork needed to move gene therapy forward into clinical trials for people with the blinding eye disorder, for which there is currently no cure.

Source: www.eurekalert.org

gene retinitis pigmentosa therapy eye national canine groundwork

Related:

• Ten people to get NHS bionic eyes - BBC News: The NHS will pay...
• FDA approves most expensive drug ever, a $3.5 million-per-dose...
• Would you pay $1 million to enroll in a phase 1 clinical trial...
• Study: Neanderthal genes are a liability for COVID patients:...
• 'Big Data' used to identify new cancer driver genes: In a collaborative...